Puma Biotechnology | Der Umsatz

Sales Veränderung Datum
Agios Pharmaceuticals USD 7.1M 296K 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Daiichi Sankyo JPY 409.62B 37.3B 2024-03
Exelixis USD 479.65M 7.73M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
Glaxosmithkline GBP 8.05B 95M 2023-12
Incyte USD 1.01B 94.32M 2023-12
MacroGenics USD 10.72M 323K 2023-12
Moderna USD 2.81B 980M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Takeda JPY 1.11T 68.1B 2023-12
TG Therapeutics USD 43.97M 121.84M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Puma Biotechnology Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.